[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368224-105":59,"doc-detail-368224-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-metacer-national-cohort-study-of-brain-metastases-in-gastrointestinal-cancers-prospectively-establishes-prognostic-factors-for-survival-outcomes","The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors for survival outcomes","","Availability data are scarce and primarily retrospective for patients with brain metastasis (BM) from gastrointestinal (GI) cancers. The METACER cohort prospectively enrolled patients with BM diagnosed during follow-up of histologically proven digestive cancer between 2010 and 2014, aiming to identify prognostic factors for survival outcomes. Primary outcome was overall survival, with secondary outcomes including progression-free survival, BM-free survival, and additional prognostic variables.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-metacer-national-cohort-study-of-brain-metastases-in-gastrointestinal-cancers-prospectively-establishes-prognostic-factors-for-survival-outcomes/368224/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-metacer-national-cohort-study-of-brain-metastases-in-gastrointestinal-cancers-prospectively-establishes-prognostic-factors-for-survival-outcomes/368224.png","ImageObject",300,407,{"name":92,"@type":93},"Hazel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of the METACER cohort study?","Question",{"text":112,"@type":113},"To determine prognostic factors for survival outcomes in patients with brain metastases from gastrointestinal cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the METACER cohort designed, and what time period was covered?",{"text":117,"@type":113},"METACER was a national multicentric prospective cohort including patients diagnosed with brain metastases during digestive cancer follow-up between 2010 and 2014.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were significantly associated with prolonged overall survival?",{"text":121,"@type":113},"Cerebral BM location (vs cerebellar), BM surgery, performance status (0–1 vs 2), and having a unique brain metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368224,1790594980,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},137441390410,"https://ap-avatar.wpscdn.com/avatar/2000252f4ab5702993?_k=1776741390130283984","Journal of Neuro-Oncology (2025) 172:229–238 [https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1060-024-04905-x  \nRESEARCH  \nThe METACER national cohort study of brain metastases in  \ngastrointestinal cancers prospectively establishes prognostic factors  \nViolaine Randrian1,2 · Fabienne Portales3 · Olivier Bouché4 · Simon Thezenas3 · Benoist Chibaudel5 · May Mabro6 · Eric Terrebonne7 · Claire Garnier-Tixidre8 · Christophe Louvet9 · Thierry André10 · Thomas Aparicio11 ·  \nOlivier Dubreuil12 · Gregoire Bouché13 · MarcYchou3 · David Tougeron1,2  \nReceived: 27 September 2024 / Accepted: 3 December 2024 / Published online: 2 January 2025 © The Author(s) 2024  \nAbstract  \nPurpose Availability data are scarce and primarily retrospective in patients with brain metastasis (BM) from gastrointestinal (GI) cancers. The objective of this cohort was to determine prognostic factors for survival outcomes in patients with BM from GI cancers.  \nMethods METACER is a national multicentric prospective cohort study which included patients with BM diagnosis during a histologically proven digestive cancer follow-up between 2010 and 2014. The primary endpoint was overall survival (OS). The secondary endpoints were Progression-Free survival (PFS), prognostic factors, and BM-free survival as time from disease diagnosis to BM diagnosis.  \nResults METACER included 130 patients, with colorectal cancer (CRC) (N= 105) and eso-gastric (N= 25) cancer (EGC) . The median OS was 6.6 months: 7.1 months (95%CI: 4.7–9.7) in CRC patients and 5.2 months,(95%CI: 1.9–7.6) in EG patients (p = 0.827) . In multivariate analysis, cerebral BM location (versus cerebellar), BM surgery, performance status (0–1 versus 2), and a unique BM were significantly associated with prolonged OS. BM-free survival were 30.8 months (95%CI:25.2–36.9) in CRC patients and 7.8 months (95%CI:3.8–13.6) in EGC patients (p \u003C0.001) . In synchronous metastatic disease, BM-free survival were 18.6 months (95%CI:13.1–25.2) in CRC patients and 3.7 months (95%CI:0.03–7.8) in EGC patients (p \u003C0.001) .  \nConclusion BM in GI cancers are of poor prognosis. BM surgery should be considered in case of unique brain lesion. In metastatic settings, EGC patients have shorter BM-free survival than CRC patients.  \nKeywords Colorectal cancer · Gastric cancer · Esophageal cancer · Metastasis · Brain metastases  \n􀀍 Violaine Randrian [violaine.randrian@chu-poitiers.fr](violaine.randrian@chu-poitiers.fr)  \n1 Department of Hepatology and Gastro-enterology, CHU de Poitiers, Poitiers, France  \n2 PRODICET, UR24144, Université de Poitiers, Poitiers, France  \n3 Department of Medical Oncology Department, Institut du Cancer de Montpellier (ICM), Montpellier, France  \n4 Department of Digestive Oncology, CHU Reims, Reims, France  \n5 Department of Medical Oncology, Hôpital FrancoBritannique – Fondation Cognacq-Jay, Cancérologie Paris Ouest, Levallois-Perret, France  \n6 Department of Oncology, Foch Hospital, GERCOR, Suresnes, France  \n7 Department of Gastroenterology, Centre Hospitalier Universitaire (CHU) Haut Lévèque, CIC 1401, Pessac, France  \n8 Department of Medical Oncology, Hôpital Privé de Provence, Aix en Provence, France  \n9 Department of Medical Oncology, Institut Mutualiste Montsouris, Paris, France  \n10 Department of Medical Oncology, Sorbonne University, Saint-Antoine Hospital, AP-HP, Paris, France  \n11 Department of Gastroenterology, APHP, Saint Louis Hospital, Université de Paris, Paris, FFCD, France  \n12 Department of Digestive Oncology, Groupe Hospitalier Diaconesses Croix Saint Simon, Paris, France  \n13 Department of Radiotherapy, Institut du Cancer Godinot, Reims, France  \nIntroduction  \nGastrointestinal (GI) cancers are rarely associated with brain metastases (BM) at cancer diagnosis [1–3] . The exact numbers of GI cancer patients with BM are not well-known, and some of them do not include upper GI cancer patients [2–7] . For instance, the Maastricht tumour registry showed a BM incidence between 1986 and 1995","cbCaiegSh6xK8k6o","https://ap.wps.com/l/cbCaiegSh6xK8k6o","pdf",1188655,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the main purpose of the METACER cohort study?\",\"answer\":\"To determine prognostic factors for survival outcomes in patients with brain metastases from gastrointestinal cancers.\"},{\"question\":\"How was the METACER cohort designed, and what time period was covered?\",\"answer\":\"METACER was a national multicentric prospective cohort including patients diagnosed with brain metastases during digestive cancer follow-up between 2010 and 2014.\"},{\"question\":\"Which factors were significantly associated with prolonged overall survival?\",\"answer\":\"Cerebral BM location (vs cerebellar), BM surgery, performance status (0–1 vs 2), and having a unique brain metastasis.\"}]","The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors for survival outcomes | PDF",1790175747,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03c0dfd90682bf2011e7b7f4a531ecd7.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f264d8f703c25d35449a121b77130b1e.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65063e02060605348da1555feaa69a55.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f246fc0a26ac84810b936ccb9ff54a5f.webp",980,1301]